ALNYLAM PHARMACEUTICALS, INC. Proceeds from (Payments for) Other Financing Activities
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Proceeds from (Payments for) Other Financing Activities of -$15.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. proceeds from (payments for) other financing activities for the quarter ending 2022-09-30 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. proceeds from (payments for) other financing activities for the quarter ending 2021-09-30 was -$6.25M.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 9 month |
|---|---|---|---|
| 2026-06-30 | -$15.00K 10-Q · filed 2026-07-30 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-30 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-07-28 | ||
| 2021-09-30 | -$6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$12.50M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | -$6.25M 10-Q · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |